World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
37293
World Ranking
10390
National Ranking
371

Viviana Galimberti publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Viviana Galimberti sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 386 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Viviana Galimberti D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Viviana Galimberti sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Viviana Galimberti is affiliated with the European Institute of Oncology in Italy and has an extensive research portfolio focused mainly on breast cancer treatment and related oncology fields. Their scholarly contributions span multiple high-impact journals and involve collaboration with several frequently co-authoring researchers.

Galimberti's recent publications include the following papers:

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 (2021, Annals of Oncology)
  • Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes (2023, JAMA Oncology)
  • Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial (2021, The Lancet Oncology)
  • Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up (2020, European Journal of Surgical Oncology)
  • Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials (2023, The Lancet)

The researcher frequently collaborates with colleagues including Paolo Veronesi, Maria Cristina Leonardi, Giovanni Corso, Francesca Magnoni, and Roberto Orecchia.

Galimberti has contributed extensively to several publication venues, notably:

  • Radiotherapy and Oncology
  • European Journal of Surgical Oncology
  • Cancer Research
  • Breast Cancer Research and Treatment
  • Annals of Surgical Oncology

Their main fields of study are Medicine and Biochemistry, Genetics and Molecular Biology, reflecting a multifaceted scientific approach.

The subfields of study predominantly covered include:

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine
  • Surgery
  • Molecular Biology

The primary topics of scientific work encompass:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Advanced Radiotherapy Techniques
  • Cancer Genomics and Diagnostics
  • Cancer Risks and Factors
  • Global Cancer Incidence and Screening

Best Publications

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

    Umberto Veronesi;Giovanni Paganelli;Viviana Galimberti;Giuseppe Viale

  • Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

    Viviana Galimberti;Bernard F. Cole;Bernard F. Cole;Stefano Zurrida;Giuseppe Viale;Giuseppe Viale

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast

    Umberto Veronesi;Alberto Luini;Marcella Del Vecchio;Marco Greco

  • Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

    U Veronesi;G Paganelli;G Viale;V Galimberti

  • Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial

    U. Veronesi;E. Marubini;L. Mariani;V. Galimberti

  • Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Patrick Maisonneuve;Giuseppe Viale;Giuseppe Viale

  • Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

    Umberto Veronesi;Giuseppe Viale;Giovanni Paganelli;Stefano Zurrida

  • Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis.

    Salvatore Pece;Michela Serresi;Elisa Santolini;Maria Capra

  • Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Giuseppe Viale;Alberto Luini;Alberto Luini

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

    H J Burstein;G Curigliano;B Thürlimann;W P Weber

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions

    Roberto Gennari;Viviana Galimberti;Concetta De Cicco;Stefano Zurrida

  • Quadrantectomy versus lumpectomy for small size breast cancer.

    Umberto Veronesi;Fabio Volterrani;Alberto Luini;Roberto Saccozzi

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

    Viviana Galimberti;Bernard F Cole;Giuseppe Viale;Giuseppe Viale;Paolo Veronesi;Paolo Veronesi

  • NUMB controls p53 tumour suppressor activity

    Ivan N. Colaluca;Daniela Tosoni;Paolo Nuciforo;Francesca Senic-Matuglia

  • Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors: A Study of Preoperative Treatment

    Marco Colleoni;Giuseppe Viale;David Zahrieh;Giancarlo Pruneri

  • Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

    U. Veronesi;G. Paganelli;V. Galimberti;G. Viale

Frequent Co-Authors

Paolo Veronesi
Paolo Veronesi European Institute of Oncology
Giuseppe Viale
Giuseppe Viale University of Milan
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Nicole Rotmensz
Nicole Rotmensz European Institute of Oncology
Roberto Orecchia
Roberto Orecchia European Institute of Oncology
Marco Colleoni
Marco Colleoni European Institute of Oncology
Giovanni Paganelli
Giovanni Paganelli Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Vincenzo Bagnardi
Vincenzo Bagnardi University of Milano-Bicocca
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Giancarlo Pruneri
Giancarlo Pruneri University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring a future in medicine but seeking flexible options, a variety of online degrees and alternative pathways can open doors to rewarding healthcare careers. Many students begin by looking for cheap rn to bsn programs to advance their nursing qualifications affordably. These programs are ideal for registered nurses wanting to earn a Bachelor of Science in Nursing (BSN) online without breaking the bank.

Prospective nurses from non-nursing backgrounds often research msn direct entry programs online, which offer an accelerated route to a Master of Science in Nursing. These programs make it possible to pivot into nursing—even if your undergraduate degree is in a completely different field.

If your goal is to start your journey quickly, you might want to consider the easiest nursing schools to get into. These schools offer accessible admissions while still providing rigorous preparation for licensure exams.

Alternatively, those interested in administrative roles may find that medical billing and coding schools that accept fafsa can create a fast track to a vital position in healthcare—often entirely online, and with the benefit of financial aid eligibility.

Best Scientists Citing Viviana Galimberti

Trending Scientists

Recently Published Articles